Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality
- PMID: 16113462
- DOI: 10.1513/pats.200404-032MS
Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality
Abstract
Chronic obstructive pulmonary disease and other disorders, associated with reduced lung function, are strong risk factors for cardiovascular events, independent of smoking. Overall, when the lowest quintile of lung function, as measured by FEV1 is compared with the highest quintile, the risk of cardiovascular mortality increases by approximately 75% in both men and women. Having symptoms of chronic bronchitis alone increases the risk of coronary deaths by 50%. Reduced ratio of FEV1 to FVC by itself is a modest independent risk factor for coronary events, increasing the risk by 30%. However, if patients have ventricular arrhythmias, the risk of coronary events is increased twofold, suggesting that the cardiotoxic effects of obstructive airways disease are amplified in those who have underlying cardiac rhythm disturbances. In general, for every 10% decrease in FEV1, all-cause mortality increases by 14%, cardiovascular mortality increases by 28%, and nonfatal coronary event increases by almost 20%. These data indicate that chronic obstructive pulmonary disease is a powerful, independent risk factor for cardiovascular morbidity and mortality.
Similar articles
-
Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.Can J Physiol Pharmacol. 2005 Jan;83(1):8-13. doi: 10.1139/y04-116. Can J Physiol Pharmacol. 2005. PMID: 15759045 Review.
-
Prognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting.Eur J Cardiothorac Surg. 2006 Feb;29(2):202-9. doi: 10.1016/j.ejcts.2005.11.015. Epub 2005 Dec 20. Eur J Cardiothorac Surg. 2006. PMID: 16376093
-
Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.Curr Opin Pulm Med. 2008 Mar;14(2):115-21. doi: 10.1097/MCP.0b013e3282f45ffb. Curr Opin Pulm Med. 2008. PMID: 18303420 Review.
-
[Chronic obstructive pulmonary disease and cardiovascular system].Tuberk Toraks. 2008;56(4):464-71. Tuberk Toraks. 2008. PMID: 19123087 Review. Turkish.
-
Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--a population-based study.Respir Med. 2008 Jan;102(1):109-20. doi: 10.1016/j.rmed.2007.07.028. Epub 2007 Oct 24. Respir Med. 2008. PMID: 17928213
Cited by
-
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.Int J Chron Obstruct Pulmon Dis. 2021 Mar 5;16:579-589. doi: 10.2147/COPD.S296472. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33707941 Free PMC article.
-
The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.Int J Mol Sci. 2024 Jul 5;25(13):7395. doi: 10.3390/ijms25137395. Int J Mol Sci. 2024. PMID: 39000502 Free PMC article. Review.
-
Epicardial adipose tissue in patients with chronic obstructive pulmonary disease.PLoS One. 2013 Jun 6;8(6):e65593. doi: 10.1371/journal.pone.0065593. Print 2013. PLoS One. 2013. PMID: 23762399 Free PMC article.
-
Economic Burden of COPD in the Presence of Comorbidities.Chest. 2015 Jul;148(1):138-150. doi: 10.1378/chest.14-2434. Chest. 2015. PMID: 25675282 Free PMC article.
-
Chronic obstructive pulmonary disease and cardiac comorbidities: A cross-sectional study.Lung India. 2016 Jul-Aug;33(4):404-9. doi: 10.4103/0970-2113.184874. Lung India. 2016. PMID: 27578933 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical